Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

A major development in an 8 On Your Side Investigation: the FBI has assigned another non-profit to take over the special ...

Symptom screening improved symptom scores among children with cancer compared with usual care, two randomized trials showed.

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the ...

ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

Q3 2024 Earnings Call Transcript November 13, 2024 Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS ...

Dr Kshetrimayum Kala SinghContd from previous issueIt is mandatory to register all the patients with necessary mobile phones, Whatsapp & e-mail for future correspondence.All the family members should ...

Additionally, we presented data at several conferences during the quarter highlighting the promising effects of inhibiting ...